Regulator defends its decision to delay use of hybrid embryos

BMJ 2007; 334 doi: (Published 08 February 2007) Cite this as: BMJ 2007;334:281
  1. Adrian O'Dowd
  1. 1London

    The fertility regulator has defended its decision to halt applications for human hybrid research in the United Kingdom during a parliamentary inquiry.

    The Human Fertilisation and Embryology Authority (HFEA), independent regulator of in vitro fertilisation treatment and embryo research in the UK, said that research involving hybrids of human and animal cells was “very new and very controversial.”

    Representatives from the authority were giving evidence to the cross party science and technology committee of MPs as part of its inquiry into government proposals to regulate the creation of animal-human hybrid embryos for research.

    The government has published a white …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to to receive unlimited access to all content on for 14 days.
    Sign up for a free trial